VIA
LEGN icon

Virtus Investment Advisers’s Legend Biotech LEGN Stock Holding History

Virtus Investment Advisers’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Sell
32,419
-5,405
-14% -$146K 0.22% 191
2026
Q1 		$684K Buy
37,824
+7,207
+24% +$137K 0.19% 182
2025
Q4 		$666K Buy
30,617
+18,895
+161% +$541K 0.18% 194
2025
Q3 		$382K Hold
11,722
– – 0.11% 232
2025
Q2 		$416K Buy
11,722
+1,606
+16% +$52K 0.14% 222
2025
Q1 		$343K Buy
+10,116
New +$363K 0.09% 230

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Virtus Investment Advisers's LEGN Position: Q2 2026 in Review

Virtus Investment Advisers reduced its Legend Biotech (LEGN) stake by 14% in Q2 2026, selling an estimated $146K and leaving 32,419 shares worth $936K. The position accounts for 0.22% of the portfolio, ranked #191.

Virtus Investment Advisers first reported a position in LEGN in Q1 2025 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Virtus Investment Advisers held 32,419 shares of Legend Biotech worth $936K as of Q2 2026.
  • Virtus Investment Advisers sold 5,405 Legend Biotech shares in Q2 2026, an estimated $146K.
  • Legend Biotech made up 0.22% of Virtus Investment Advisers's portfolio in Q2 2026, its #191 holding.
  • Virtus Investment Advisers first reported a position in Legend Biotech in Q1 2025 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.